Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Anti-dumping duty imposed on Ofloxacin import from China

The levy has been slapped following the recommendations of the Directorate General of Anti-Dumping and Allied Duties (DGAD). Aarti Drugs had approached the DGAD for initiation of anti-dumping investigation and imposition of the duty concerning imports of Ofloxacin, originating in or exported from China.

The experts discussed the formation of a model that is collaborative with like-minded institutions trying to make an impact across various verticals of healthcare.
We will need to focus on true breakthroughs, therapies that are truly transformative - either life enhancing or meaningfully life changing.
Sun Pharma in a BSE filing said that its net profit was adversely impacted by one-time deferred tax adjustment of Rs 513 crore related to changes in US tax rates.